Nuveen
CABA icon

Nuveen’s Cabaletta Bio CABA Stock Holding History

Nuveen’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Buy
+646,345
New +$2.13M ﹤0.01% 2569
2025
Q2 		– Sell
-434,389
Closed -$602K – 3290
2025
Q1 		$602K Hold
434,389
– – ﹤0.01% 2842
2024
Q4 		$986K Hold
434,389
– – ﹤0.01% 2719
2024
Q3 		$2.05M Buy
434,389
+272,085
+168% +$1.57M ﹤0.01% 2399
2024
Q2 		$1.21M Sell
162,304
-35,733
-18% -$438K ﹤0.01% 2636
2024
Q1 		$3.38M Sell
198,037
-43,750
-18% -$939K ﹤0.01% 2161
2023
Q4 		$5.49M Buy
241,787
+105,809
+78% +$1.78M ﹤0.01% 1927
2023
Q3 		$2.07M Buy
135,978
+53,910
+66% +$737K ﹤0.01% 2280
2023
Q2 		$1.06M Buy
+82,068
New +$891K ﹤0.01% 2636
2021
Q2 		– Sell
-68,401
Closed -$759K – 3383
2021
Q1 		$759K Buy
68,401
+59
+0.1% +$721 ﹤0.01% 2982
2020
Q4 		$853K Buy
68,342
+214
+0.3% +$2.78K ﹤0.01% 2864
2020
Q3 		$738K Buy
68,128
+22,708
+50% +$261K ﹤0.01% 2811
2020
Q2 		$506K Buy
45,420
+28,869
+174% +$221K ﹤0.01% 2892
2020
Q1 		$121K Buy
16,551
+6,194
+60% +$84.9K ﹤0.01% 3051
2019
Q4 		$145K Buy
+10,357
New +$123K ﹤0.01% 3099

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Nuveen's CABA Position: Q2 2026 in Review

Nuveen opened a new position in Cabaletta Bio (CABA) in Q2 2026: 646,345 shares worth $2.01M. The stake represents ﹤0.01% of the portfolio and ranks #2569 among its holdings. This is a return to the name: Nuveen previously reported a position in CABA as recently as Q1 2025.

Nuveen first reported a position in CABA in Q4 2019 and has held it in 15 quarters since. The position peaked at $5.49M in Q4 2023. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Nuveen held 646,345 shares of Cabaletta Bio worth $2.01M as of Q2 2026.
  • Cabaletta Bio was a new Nuveen position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2569 holding.
  • Nuveen first reported a position in Cabaletta Bio in Q4 2019 and has held it in 15 quarters since.
  • Nuveen's Cabaletta Bio position peaked at $5.49M in Q4 2023.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.